4//SEC Filing
INTERCEPT PHARMACEUTICALS INC 4
Accession 0001144204-14-042176
CIK 0001270073operating
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 9:00 PM ET
Size
10.4 KB
Accession
0001144204-14-042176
Insider Transaction Report
Form 4
TALLARIGO LORENZO
Director
Transactions
- Exercise/Conversion
Common Stock
2014-07-07$9.82/sh+2,000$19,645→ 2,000 total - Sale
Common Stock
2014-07-07$242.11/sh−1,000$242,110→ 1,000 total - Sale
Common Stock
2014-07-07$244.00/sh−1,000$244,000→ 0 total - Exercise/Conversion
Option to Purchase Common Stock
2014-07-07−2,000→ 4,923 totalExercise: $9.82Exp: 2018-09-18→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 18, 2013.
- [F2]All shares underlying this option are fully vested.
Documents
Issuer
INTERCEPT PHARMACEUTICALS INC
CIK 0001270073
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001270073
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 9:00 PM ET
- Size
- 10.4 KB